Companies: 10,795·Total market cap: $144.5T
Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp.

ORIANASDAQFinancial Services
$10.23
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$12.0
52W Low$9.71
SEC Filings

Orion Biotech Opportunities Corp. (ORIA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001847416 · ORIA · NASDAQ · as of Jun 9, 2026

Filing snapshot

50
Total Filings
SC 13G/A
Latest Form
2024-02-14
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001847416 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-29
Fiscal Year End
Mar 29, 2023
Accession No.
0001213900-23-024075
Primary Document
f10k2022_orionbiotech.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001847416 · Accession 0001213900-23-024075

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2022-11-10
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2023-04-24Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
683 CAPITAL MANAGEMENT, LLC
2024-02-14
View
15-12G15-12G
FORM 15-12G
2023-05-11
View
2525
FORM 25
2023-05-01
View
8-KCurrent Report
CURRENT REPORT
2023-04-24
View
10-KAnnual Report
ANNUAL REPORT
2023-03-29
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2023-02-14
View
10-QQuarterly Report
QUARTERLY REPORT
2022-11-10
View
10-QQuarterly Report
QUARTERLY REPORT
2022-08-12
View
10-QQuarterly Report
QUARTERLY REPORT
2022-05-11
View
10-KAnnual Report
ANNUAL REPORT
2022-03-24
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2022-02-14
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2022-02-14
View
10-Q/AQuarterly Report (Amended)
AMENDMENT NO. 1 TO FORM 10-Q
2021-12-20
View
425425
CURRENT REPORT
2021-12-20
View
8-KCurrent Report
CURRENT REPORT
2021-12-20
View
Showing 1–15 of 45 filingsForm 4 / 144 hidden· 50 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001847416  |  Exchange: NASDAQ · Financial Services

Orion Biotech Opportunities Corp. (NASDAQ: ORIA) has submitted 50 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Financial Services sector company with CIK 0001847416, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Orion Biotech Opportunities Corp.'s most comprehensive regulatory disclosure. The most recent Orion Biotech Opportunities Corp. 10-K was filed on 2023-03-29 for fiscal year ending 2023. Historical ORIA 10-K annual reports are available from 2021 through 2023.

Investors researching Orion Biotech Opportunities Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Financial Services
FRON SEC Filings →TRTL SEC Filings →GVCI SEC Filings →CRZN SEC Filings →TBSA SEC Filings →BGSX SEC Filings →APTM SEC Filings →
→ ORIA Financials→ ORIA Earnings→ ORIA Insider Trades

Frequently Asked Questions

ORIA SEC Filings · 8 questions

Orion Biotech Opportunities Corp. (ORIA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 50 filings and access original documents at no cost. Orion Biotech Opportunities Corp.'s CIK is 0001847416.

ORIA SEC filingsOrion Biotech Opportunities Corp. SEC documentsfind ORIA 10-K